Evidence map›Paper›PMID 31975920›Full record

ReviewFocus (American Psychiatric Publishing)2018

Whole-Body Heating: An Emerging Therapeutic Approach to Treatment of Major Depressive Disorder.

Christopher Lowry, Michael Flux, Charles Raison

Abstract readReview
In one paragraph

Review in Focus (American Psychiatric Publishing), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT).International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Emerging Therapies in Psychiatry.Focus (American Psychiatric Publishing) · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher LowryDr. Lowry is with the Department of Integrative Physiology and Center for Neuroscience, University of Colorado, Boulder. Mr. Flux is with the Department of Psychology and Neuroscience, University of Colorado, Boulder. Dr. Raison is with the School of Human Ecology and the School of Medicine and Public Health, University of Wisconsin-Madison.
Michael FluxDr. Lowry is with the Department of Integrative Physiology and Center for Neuroscience, University of Colorado, Boulder. Mr. Flux is with the Department of Psychology and Neuroscience, University of Colorado, Boulder. Dr. Raison is with the School of Human Ecology and the School of Medicine and Public Health, University of Wisconsin-Madison.
Charles RaisonDr. Lowry is with the Department of Integrative Physiology and Center for Neuroscience, University of Colorado, Boulder. Mr. Flux is with the Department of Psychology and Neuroscience, University of Colorado, Boulder. Dr. Raison is with the School of Human Ecology and the School of Medicine and Public Health, University of Wisconsin-Madison.

Funding

Mycobacterium vaccae and stress resilience: Neural mechanismsR21MH116263 · NIMH · UNIVERSITY OF COLORADO · PI FRANK, MATTHEW G, LOWRY, CHRISTOPHER A · 2018 to 2019
$424k
NIMH NIH HHS R21 MH116263RRD VA I21 RX002232
6 · The paper itself

Abstract

Major depressive disorder is the leading cause of disability worldwide. Currently available pharmacological approaches to the treatment of depression (which are the mainstay of treatment in the United States) suffer from important shortcomings, including limited efficacy, delayed onset of action, increased relapse risk upon withdrawal, and significant side effects that impair quality of life and promote treatment nonadherence and/or discontinuation. There is an emerging interest in the potential use of evolutionarily conserved interoceptive pathways (i.e., pathways that relay sensory information, related to the internal, physiologic state of the body, from the periphery to the central nervous system) as "gateways" to neural systems controlling affective and cognitive function relevant to the pathophysiology of depression. In support of the potential utility of this approach, we have shown in open and randomized, double-blind, sham-controlled trials that infrared whole-body heating has significant and long-lasting antidepressant effects relative to a sham condition. In this review, we explore the potential role of thermosensory pathways in the etiology, pathophysiology, and symptomatology of major depressive disorder, as well as its potential as a novel therapeutic approach to the treatment of major depressive disorder.

Indexed as

Antidepressantsinfraredmajor depressive disorderthermosensation

Identifiers

PMID31975920
PMCPMC6493094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.